Quinoline compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822078
SERIAL NO

15121973

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to quinoline compounds as defined by Formula I below. Such quinoline compounds have been shown to inhibit the formation of amyloid deposits (e.g., amyloid oligomers, fibrils or plaques). Consequently, these compounds are suitable for treating a range of diseases and disorders in which amyloid deposits are implicated, such as type-2 diabetes and Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OXFORD UNIVERSITY INNOVATION LIMITEDBUXTON COURT 3 WEST WAY OXFORD OX2 0JB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bataille, Carole Oxford, GB 3 0
Brennan, Méabh London, GB 1 0
Davies, Stephen Oxford, GB 58 849
Jean, Letitia Oxford, GB 1 0
Russell, Angela Oxford, GB 3 0
Vaux, David Oxford, GB 4 48
Wynne, Graham Oxford, GB 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00